stockportfolio.pro
Stocks / BRKR vs OSCR
BRKR vs OSCR
Bruker Corporation and Oscar Health, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.
| Bruker Corporation (BRKR) | Oscar Health, Inc. (OSCR) | |
|---|---|---|
| Market cap | $8.4B | $8.5B |
| Revenue (latest FY) | $3.44B | $11.70B |
| Net income (latest FY) | $-22.50M | $-443.15M |
| Revenue growth (5y CAGR) | 11.6% | 90.8% |
| Net margin | -0.7% | -3.8% |
| Return on equity | -0.9% | -45.3% |
| P/E ratio | — | — |
| Dividend yield | 0.3% | — |
| Profitable years (of last 10) | 9 | 1 |
| Positive free cash flow | Yes | Yes |
Compare them properly — statement by statement
Open either company interactively: 19 years of income statement, balance sheet and cash flow, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open BRKR — free Open OSCR — freeFrequently asked questions
Which is bigger, BRKR or OSCR?
Oscar Health, Inc. is larger by market capitalization — $8.5B versus $8.4B.
Which grows faster, BRKR or OSCR?
Over the last five fiscal years, Oscar Health, Inc. grew revenue faster — 90.8%/yr versus 11.6%/yr, computed from SEC-filed statements.
Where does this data come from?
All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.